Michael Wacker

Co-founder, Chief Scientific Officer; Board Member

 

Michael Wacker co-founded GlycoVaxyn in 2004 and is now responsible for its technology and product development, as well as development collaborations.

He invented GlycoVaxyn's technology with Professor Markus Aebi at the Institute of Microbiology of the Swiss Federal Institute of Technology (ETH) during his PhD and post-doctoral research. He is the author of several publications in international scientific journals, including Science and PNAS. He graduated in biochemistry from the ETH in Zurich.